Neumora Therapeutics (NMRA) Return on Equity [ROE] (2023 - 2026)
Neumora Therapeutics (NMRA) reported Return on Equity [ROE] of -369.36% for Q2 2026, down 246.76 percentage points from -122.60% a year earlier and down 114.53 percentage points from the prior quarter.
Powered by 
Analysis
Neumora Therapeutics (NMRA) Return on Equity [ROE] (2023 - 2026) Analysis & Trends
For FY2025, Neumora Therapeutics posted Return on Equity [ROE] of -121.21%, down 56.73 percentage points from FY2024.
- By year, Return on Equity [ROE] came in at -64.48% in FY2024 (+2058.48 pp) and -2122.96% in FY2023.
- The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] in data going back to Q4 2023.
- Year over year, Return on Equity [ROE] has now declined in each of the last seven quarters, with an average year-over-year change of -102.55 percentage points over the last seven quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at -254.82% (Q1 2026), -200.76% (Q4 2025) and -150.01% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Neumora Therapeutics | 88.31 Mn | -529.65 Mn | - | -369.33% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -369.33% |
| Mar 31, 2026 | -254.81% |
| Dec 31, 2025 | -200.81% |
| Sep 30, 2025 | -150.07% |
| Jun 30, 2025 | -122.51% |
| Mar 31, 2025 | -100.08% |
| Dec 31, 2024 | -80.17% |
| Sep 30, 2024 | -83.56% |
| Jun 30, 2024 | -67.99% |
| Mar 31, 2024 | -56.82% |
| Dec 31, 2023 | -47.92% |
API Access
Neumora Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "NMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();